The purpose of the HCT/P Modernization Act of 2025 is to improve the regulatory oversight of human cell and tissue products. This legislation aims to make the process more efficient and transparent, ensuring that these products are regulated effectively while also promoting scientific advancements in the field. Key provisions of the Act include several important actions. First, the Secretary of Health and Human Services is required to create and publish educational materials about the Tissue Reference Group, which is part of the Food and Drug Administration (FDA).